AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
AIM Vaccine Co., Ltd. has reported a slight decrease in revenue and a significant reduction in gross profit for the first half of 2024, with a notable improvement in lowering its loss attributable to owners by 44.42% compared to the same period in 2023. The financial results indicate a tightening in overall operational expenses despite a challenging period.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.